1 active not recruiting, 1 recruiting, 1 terminated, 1 unknown. 4 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Klatskin Tumor: new trials by email Literature Review of Klatskin Tumor trials Research Report on Klatskin Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma Pembrolizumab, Gemcitabine, Cisplatin - Extrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma | Phase 2 / Phase 3 | Recruiting | Amsterdam UMC, location VUmc | 150 | 2026-04-17 | 2026-08-25 |
| Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) Rilvegostomig, Placebo, Capecitabine - Biliary Tract Cancer | Phase 3 | Active not recruiting | AstraZeneca | 760 | 2023-12-04 | 2026-10-16 |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) Photodynamic therapy-Photofrin, Stenting procedure, Chemotherapy regimen - Hilar Cholangiocarcinoma | Phase 3 | Terminated | Concordia Laboratories Inc. | 28 | 2014-11-12 | 2019-08-28 |
| Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma bilateral metal stent insertion, unilateral metal stent insertion - Hilar Cholangiocarcinoma | Phase 2 / Phase 3 | Unknown | Air Force Military Medical University, China | 70 | 2014-07-01 | 2019-08-01 |
Cholangiocarcinoma (4) · Bile Duct Neoplasms (2) · Biliary Tract Neoplasms (1) · Gallbladder Neoplasms (1) · Jaundice (1)
Adenocarcinoma (4) · Carcinoma (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Bile Duct Diseases (2) · Biliary Tract Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms by Site (2) · Biliary Tract Neoplasms (1) · Gallbladder Diseases (1) · Hyperbilirubinemia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Cisplatin (3) · Gemcitabine (3) · Capecitabine (1) · Drug Therapy (1) · S 1 (combination) (1) · Tegafur (1) · pembrolizumab (1)
Air Force Military Medical University, China (1) · Amsterdam UMC, location VUmc (1) · AstraZeneca (1) · Concordia Laboratories Inc. (1)
Canada (2) · China (2) · Germany (2) · South Korea (2) · United States (2) · Australia (1) · Belgium (1) · Brazil (1) · Denmark (1) · France (1) · Hong Kong (1) · India (1) · Italy (1) · Japan (1) · Netherlands (1)
Guohong Han, MD,Ph.D (1) · Michel Kahaleh, MD (1)
2023 (1)